Report Detail

Medical Devices & Consumables COVID-19 Impact on Global Artemisinin Combination Therapy Market Size, Status and Forecast 2020-2026

  • RnM4066575
  • |
  • 17 June, 2020
  • |
  • Global
  • |
  • 91 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

This report focuses on the global Artemisinin Combination Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Artemisinin Combination Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
KPC Pharmaceuticals
Shanghai Fosun Pharmaceutical Industrial Development
Sanofi
Desano Holdings
Calyx Chemicals and Pharmaceuticals
Mylan
Novartis
Denk Pharma
Hovid Berhad
Ipca Laboratories
Cipla
Aspen Pharmacare Holdings
Ajanta Pharma
Guilin Pharmaceuticals

Market segment by Type, the product can be split into
Artemether+Lumefantrine
Artesunate+Amodiaquine
Dihydroartemisinin+Piperaquine
Artesunate+Mefloquine
Artesunate+Sulfadoxine-Pyrimethamine
Pyronaridine-Artesunate
Other
Market segment by Application, split into
Hospital
Clinic
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Artemisinin Combination Therapy status, future forecast, growth opportunity, key market and key players.
To present the Artemisinin Combination Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Artemisinin Combination Therapy are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Artemisinin Combination Therapy Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Artemisinin Combination Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Artemether+Lumefantrine
    • 1.4.3 Artesunate+Amodiaquine
    • 1.4.4 Dihydroartemisinin+Piperaquine
    • 1.4.5 Artesunate+Mefloquine
    • 1.4.6 Artesunate+Sulfadoxine-Pyrimethamine
    • 1.4.7 Pyronaridine-Artesunate
    • 1.4.8 Other
  • 1.5 Market by Application
    • 1.5.1 Global Artemisinin Combination Therapy Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital
    • 1.5.3 Clinic
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Artemisinin Combination Therapy Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Artemisinin Combination Therapy Industry
      • 1.6.1.1 Artemisinin Combination Therapy Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Artemisinin Combination Therapy Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Artemisinin Combination Therapy Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Artemisinin Combination Therapy Market Perspective (2015-2026)
  • 2.2 Artemisinin Combination Therapy Growth Trends by Regions
    • 2.2.1 Artemisinin Combination Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Artemisinin Combination Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Artemisinin Combination Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Artemisinin Combination Therapy Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Artemisinin Combination Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Artemisinin Combination Therapy Players by Market Size
    • 3.1.1 Global Top Artemisinin Combination Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Artemisinin Combination Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Artemisinin Combination Therapy Market Concentration Ratio
    • 3.2.1 Global Artemisinin Combination Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Artemisinin Combination Therapy Revenue in 2019
  • 3.3 Artemisinin Combination Therapy Key Players Head office and Area Served
  • 3.4 Key Players Artemisinin Combination Therapy Product Solution and Service
  • 3.5 Date of Enter into Artemisinin Combination Therapy Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Artemisinin Combination Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Artemisinin Combination Therapy Forecasted Market Size by Type (2021-2026)

5 Artemisinin Combination Therapy Breakdown Data by Application (2015-2026)

  • 5.1 Global Artemisinin Combination Therapy Market Size by Application (2015-2020)
  • 5.2 Global Artemisinin Combination Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Artemisinin Combination Therapy Market Size (2015-2020)
  • 6.2 Artemisinin Combination Therapy Key Players in North America (2019-2020)
  • 6.3 North America Artemisinin Combination Therapy Market Size by Type (2015-2020)
  • 6.4 North America Artemisinin Combination Therapy Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Artemisinin Combination Therapy Market Size (2015-2020)
  • 7.2 Artemisinin Combination Therapy Key Players in Europe (2019-2020)
  • 7.3 Europe Artemisinin Combination Therapy Market Size by Type (2015-2020)
  • 7.4 Europe Artemisinin Combination Therapy Market Size by Application (2015-2020)

8 China

  • 8.1 China Artemisinin Combination Therapy Market Size (2015-2020)
  • 8.2 Artemisinin Combination Therapy Key Players in China (2019-2020)
  • 8.3 China Artemisinin Combination Therapy Market Size by Type (2015-2020)
  • 8.4 China Artemisinin Combination Therapy Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Artemisinin Combination Therapy Market Size (2015-2020)
  • 9.2 Artemisinin Combination Therapy Key Players in Japan (2019-2020)
  • 9.3 Japan Artemisinin Combination Therapy Market Size by Type (2015-2020)
  • 9.4 Japan Artemisinin Combination Therapy Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Artemisinin Combination Therapy Market Size (2015-2020)
  • 10.2 Artemisinin Combination Therapy Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Artemisinin Combination Therapy Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Artemisinin Combination Therapy Market Size by Application (2015-2020)

11 India

  • 11.1 India Artemisinin Combination Therapy Market Size (2015-2020)
  • 11.2 Artemisinin Combination Therapy Key Players in India (2019-2020)
  • 11.3 India Artemisinin Combination Therapy Market Size by Type (2015-2020)
  • 11.4 India Artemisinin Combination Therapy Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Artemisinin Combination Therapy Market Size (2015-2020)
  • 12.2 Artemisinin Combination Therapy Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Artemisinin Combination Therapy Market Size by Type (2015-2020)
  • 12.4 Central & South America Artemisinin Combination Therapy Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 KPC Pharmaceuticals
    • 13.1.1 KPC Pharmaceuticals Company Details
    • 13.1.2 KPC Pharmaceuticals Business Overview and Its Total Revenue
    • 13.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Introduction
    • 13.1.4 KPC Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2015-2020))
    • 13.1.5 KPC Pharmaceuticals Recent Development
  • 13.2 Shanghai Fosun Pharmaceutical Industrial Development
    • 13.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Details
    • 13.2.2 Shanghai Fosun Pharmaceutical Industrial Development Business Overview and Its Total Revenue
    • 13.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Introduction
    • 13.2.4 Shanghai Fosun Pharmaceutical Industrial Development Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 13.2.5 Shanghai Fosun Pharmaceutical Industrial Development Recent Development
  • 13.3 Sanofi
    • 13.3.1 Sanofi Company Details
    • 13.3.2 Sanofi Business Overview and Its Total Revenue
    • 13.3.3 Sanofi Artemisinin Combination Therapy Introduction
    • 13.3.4 Sanofi Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 13.3.5 Sanofi Recent Development
  • 13.4 Desano Holdings
    • 13.4.1 Desano Holdings Company Details
    • 13.4.2 Desano Holdings Business Overview and Its Total Revenue
    • 13.4.3 Desano Holdings Artemisinin Combination Therapy Introduction
    • 13.4.4 Desano Holdings Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 13.4.5 Desano Holdings Recent Development
  • 13.5 Calyx Chemicals and Pharmaceuticals
    • 13.5.1 Calyx Chemicals and Pharmaceuticals Company Details
    • 13.5.2 Calyx Chemicals and Pharmaceuticals Business Overview and Its Total Revenue
    • 13.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Introduction
    • 13.5.4 Calyx Chemicals and Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 13.5.5 Calyx Chemicals and Pharmaceuticals Recent Development
  • 13.6 Mylan
    • 13.6.1 Mylan Company Details
    • 13.6.2 Mylan Business Overview and Its Total Revenue
    • 13.6.3 Mylan Artemisinin Combination Therapy Introduction
    • 13.6.4 Mylan Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 13.6.5 Mylan Recent Development
  • 13.7 Novartis
    • 13.7.1 Novartis Company Details
    • 13.7.2 Novartis Business Overview and Its Total Revenue
    • 13.7.3 Novartis Artemisinin Combination Therapy Introduction
    • 13.7.4 Novartis Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 13.7.5 Novartis Recent Development
  • 13.8 Denk Pharma
    • 13.8.1 Denk Pharma Company Details
    • 13.8.2 Denk Pharma Business Overview and Its Total Revenue
    • 13.8.3 Denk Pharma Artemisinin Combination Therapy Introduction
    • 13.8.4 Denk Pharma Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 13.8.5 Denk Pharma Recent Development
  • 13.9 Hovid Berhad
    • 13.9.1 Hovid Berhad Company Details
    • 13.9.2 Hovid Berhad Business Overview and Its Total Revenue
    • 13.9.3 Hovid Berhad Artemisinin Combination Therapy Introduction
    • 13.9.4 Hovid Berhad Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 13.9.5 Hovid Berhad Recent Development
  • 13.10 Ipca Laboratories
    • 13.10.1 Ipca Laboratories Company Details
    • 13.10.2 Ipca Laboratories Business Overview and Its Total Revenue
    • 13.10.3 Ipca Laboratories Artemisinin Combination Therapy Introduction
    • 13.10.4 Ipca Laboratories Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 13.10.5 Ipca Laboratories Recent Development
  • 13.11 Cipla
    • 10.11.1 Cipla Company Details
    • 10.11.2 Cipla Business Overview and Its Total Revenue
    • 10.11.3 Cipla Artemisinin Combination Therapy Introduction
    • 10.11.4 Cipla Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 10.11.5 Cipla Recent Development
  • 13.12 Aspen Pharmacare Holdings
    • 10.12.1 Aspen Pharmacare Holdings Company Details
    • 10.12.2 Aspen Pharmacare Holdings Business Overview and Its Total Revenue
    • 10.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Introduction
    • 10.12.4 Aspen Pharmacare Holdings Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 10.12.5 Aspen Pharmacare Holdings Recent Development
  • 13.13 Ajanta Pharma
    • 10.13.1 Ajanta Pharma Company Details
    • 10.13.2 Ajanta Pharma Business Overview and Its Total Revenue
    • 10.13.3 Ajanta Pharma Artemisinin Combination Therapy Introduction
    • 10.13.4 Ajanta Pharma Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 10.13.5 Ajanta Pharma Recent Development
  • 13.14 Guilin Pharmaceuticals
    • 10.14.1 Guilin Pharmaceuticals Company Details
    • 10.14.2 Guilin Pharmaceuticals Business Overview and Its Total Revenue
    • 10.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Introduction
    • 10.14.4 Guilin Pharmaceuticals Revenue in Artemisinin Combination Therapy Business (2015-2020)
    • 10.14.5 Guilin Pharmaceuticals Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Artemisinin Combination Therapy. Industry analysis & Market Report on COVID-19 Impact on Global Artemisinin Combination Therapy is a syndicated market report, published as COVID-19 Impact on Global Artemisinin Combination Therapy Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Artemisinin Combination Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,603.60
    5,405.40
    7,207.20
    590,031.00
    885,046.50
    1,180,062.00
    325,143.00
    487,714.50
    650,286.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report